Safety data of MGN1601, a tumor vaccine, made of allogeneic, transfected, and irradiated tumor cells in combination with an immunomodulator for the treatment of metastatic renal cell carcinoma

Autor:	Kerstin Kapp, Matthias Schroff, Martina Schmidt, Marina Tschaika, Barbara Volz, Burghardt Wittig, C. Kleuss
Rok vydání:	2010
Předmět:	Active ingredient Cancer Research Pathology medicine.medical_specialty business.industry Cell Tumor cells Transfection urologic and male genital diseases medicine.disease Genetically modified organism medicine.anatomical_structure Oncology Renal cell carcinoma medicine business
Zdroj:	Journal of Clinical Oncology. 28:e15104-e15104
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.e15104
Popis:	e15104 Background: The cell-based tumor vaccine MGN1601 for the treatment of renal cell carcinoma (RCC), consists of two active pharmaceutical ingredients: First, genetically modified allogeneic (h...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::07a4131434c5fb12990956d21e144ac5 https://doi.org/10.1200/jco.2010.28.15_suppl.e15104 Zobrazit plný text záznamu